(Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that it has entered into a securities purchase agreement for a private placement of approximately $85 million in upfront gross ...
Agenus (AGEN) shares rose 13% in premarket trading on Monday after the immuno-oncology company announced an $85M private placement, with the potential to raise up to an additional $255M if purchase ...
Bryan Johnson says AI, blood tests, and specialised imaging diagnosed his girlfriend's endometriosis without surgery, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results